SCHEMBL4943809

SCHEMBL4943809

NCC(=O)ON(c1ccccc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.40
ADRA2C P18825 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KMT2A Q03164 2/20 0.38
HTT P42858 2/20 0.38
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.38
RAB9A P51151 1/20 0.38
GLA P06280 1/20 0.38
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28777147 0.82 NPSR1 (0.41) NPSR1ALDH1A1KMT2AHTTNPC1
SCHEMBL4428614 0.77 NPSR1 (0.44) NPSR1ALDH1A1KMT2AHTTNPC1
SCHEMBL11496421 0.77 ALDH1A1 (0.37) NPSR1ADRA2CALDH1A1KMT2AHTT
SCHEMBL28995069 0.77 ALDH1A1 (0.44) NPSR1ADRA2CALDH1A1KMT2AHTT
SCHEMBL9348371 0.76 NPSR1 (0.48) NPSR1ALDH1A1KMT2AHTTNPC1
SCHEMBL28581000 0.76 NPSR1 (0.48) NPSR1ALDH1A1KMT2AHTTNPC1
SCHEMBL27599059 0.73 CYP3A4 (0.46) ALDH1A1NPC1RAB9AGLATSHR
SCHEMBL6851360 0.72 LMNA (0.56) NPSR1ALDH1A1KMT2APOLBTSHR
SCHEMBL4467640 0.72 NPSR1 (0.44) NPSR1ALDH1A1KMT2AHTTNPC1
SCHEMBL9331004 0.72 CES2 (0.49) ALDH1A1KMT2ANPC1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080280945-A1 Crystalline forms of an HIV integrase inhibitor MERCK SHARP & DOHME CORP. 2008-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280945-A1 Crystalline forms of an HIV integrase inhibitor TYMP, SAMHD1, ACIN1 NPSR1 4512/4885ADRA2C 4447/4885ALDH1A1 3635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.